You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adriamycin

Showing 1 - 25 of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solitary Fibrous Tumors Trial in Italy (Trabectedin, Adriamycin, Dacarbazine)

Recruiting
  • Solitary Fibrous Tumors
  • Prato, Firenze, Italy
  • +5 more
Oct 29, 2021

Classical Hodgkin Lymphoma Trial in Cologne (Nivolumab, Adriamycin, Vinblastine)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Cologne, Germany
    University Hospital of Cologne
Aug 5, 2022

Inflammatory Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Boston (Eribulin, Adriamycin,

Active, not recruiting
Has Results
  • Inflammatory Breast Cancer
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • Boston, Massachusetts
  • +1 more
Nov 28, 2022

Multiple Myeloma Trial in Little Rock (Carfilzomib, Thalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 1, 2022

Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Tumors Trial in Frankfurt (Adriamycin, Cyclophosphamide, Cytarabine)

Completed
  • Burkitt's Lymphoma
  • +4 more
  • Adriamycin
  • +10 more
  • Frankfurt, Germany
    University Hospital, Medical Dept. II
Aug 17, 2022

Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)

Completed
  • Adult Acute Lymphocytic Leukemia
  • Frankfurt, Germany
    University of Frankfurt, Medical Dept. II
Aug 17, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Frankfurt (Main), Germany
    University Hospital of Frankfurt (Main)
Jul 1, 2022

Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)

Active, not recruiting
  • Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Dec 1, 2021

Advanced Solid Tumors Trial in China (MASCT-I, Ifosfamide, PD1 antibody)

Recruiting
  • Advanced Solid Tumors
  • MASCT-I
  • +6 more
  • Beijing, Beijing, China
  • +8 more
Dec 29, 2022

Soft Tissue Sarcoma, Tumors, Connective and Soft Tissue, Sarcoma Metastatic Trial in Wuhan (Camrelizumab, Adriamycin)

Recruiting
  • Soft Tissue Sarcoma
  • +3 more
  • Wuhan, Hubei, China
    Union Hospital，Tongji Medical College, Huazhong University of Sc
Jun 1, 2021

Unresectable Sinonasal Tumors Trial in Italy (Cisplatin, Docetaxel, 5-fluorouracil)

Active, not recruiting
  • Unresectable Sinonasal Tumors
  • Brescia, BS, Italy
  • +4 more
Apr 8, 2022

Sinonasal Tumors Trial in Italy (Cisplatin, Docetaxel, 5-fluorouracil)

Active, not recruiting
  • Sinonasal Tumors
  • Brescia, BS, Italy
  • +4 more
Apr 8, 2022

Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 7, 2021

Advanced Hodgkin Lymphoma Trial in Worldwide (Brentuximab Vedotin, Adriamycin, Vinblastine)

Active, not recruiting
  • Advanced Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +6 more
  • Antwerp, Belgium
  • +18 more
May 4, 2022

Hodgkin Lymphoma Trial in Boston (Brentuximab Vedotin, Adriamycin, Dacarbazine)

Completed
Has Results
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 10, 2020

Hodgkin Lymphoma Trial in France (brentuximab vedotin, Cyclophosphamide, Adriamycin)

Completed
  • Hodgkin Lymphoma
  • brentuximab vedotin
  • +9 more
  • Argenteuil, France
  • +29 more
Jul 23, 2021

Classical Hodgkin Lymphoma, Hodgkin Lymphoma (Category), Hodgkin Disease Trial in Riyadh (Adriamycin, Cyclophosphamide,

Unknown status
  • Classical Hodgkin Lymphoma
  • +3 more
  • Adriamycin
  • +5 more
  • Riyadh, Saudi Arabia
    King Abdulaziz Medical City, Ministry of National Guard
Nov 14, 2019

Sarcoma Trial in Houston (Aranesp (darbepoetin alfa), Neulasta (pegfilgrastim), Adriamycin)

Completed
  • Sarcoma
  • Aranesp (darbepoetin alfa)
  • +3 more
  • Houston, Texas
    UT MDAnderson Cancer Center
Nov 5, 2018

Breast Cancer Trial in Canada, United States (herceptin, adriamycin, cyclophosphamide)

Completed
  • Breast Cancer
  • herceptin
  • +3 more
  • Huntsville, Alabama
  • +148 more
Apr 28, 2021

Hodgkin Disease Trial in Houston (Filgrastim SD/01, Adriamycin, Bleomycin)

Completed
  • Hodgkin Disease
  • Filgrastim SD/01
  • +4 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 30, 2018

Leukemia, Acute, Leukemia, T Cell, Leukemia, Lymphoblastic Trial in Guangzhou (drug, procedure, radiation, genetic, diagnostic

Unknown status
  • Leukemia, Acute
  • +2 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Jun 11, 2018

Multiple Myeloma Trial in Little Rock (Cisplatin, Cyclophosphamide, Adriamycin)

Completed
Has Results
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences/MIRT
Oct 17, 2017

Leukemia, Leukemia, Acute, Adult Lymphoblastic Lymphoma Trial in Guangzhou (drug, procedure, radiation, genetic, diagnostic

Unknown status
  • Leukemia
  • +7 more
  • Guangzhou, Guangdong, China
    Department of Hematology, Nanfang Hospital
Jun 11, 2018

Breast Cancer Trial in Canada, Puerto Rico, United States (cyclophosphamide, adriamycin, epirubicin)

Completed
  • Breast Cancer
  • Huntsville, Alabama
  • +605 more
Jun 3, 2016

Multiple Myeloma Trial in Worldwide (adriamycin, bortezomib, dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • adriamycin
  • +3 more
  • Zagreb, Croatia
  • +15 more
Feb 20, 2014